Hep C Discussion Forum

Members Login
Username 
 
Password 
    Remember Me  
Chatbox
Please log in to join the chat!
Post Info TOPIC: HEP C NEWS---NEW DRUG


Senior Member

Status: Offline
Posts: 133
Date:
HEP C NEWS---NEW DRUG
Permalink  
 


Hep C Trial with Sovaprevir Has 85% Success Rate

August 20, 2012

 

  • In a mid-stage trial, Achillion's experimental drug, sovaprevir, demonstrated an excellent efficacy rate and safety profile.

Achillion hepatitis C drug shows promise in mid-stage study

Tue Aug 7, 2012 8:37pm EDT

(Reporting by Zeba Siddiqui in Bangalore; Editing by Anthony Kurian)

(Reuters) - Achillion Pharmaceuticals Inc said its experimental hepatitis C drug showed promising interim data in a mid-stage trial, sending its shares higher in extended trade.

The company said the drug sovaprevir, when given along with the standard therapy of pegylated interferon and ribavirin, showed no detectable virus level in a majority of patients four weeks after the end of the treatment period.

Of the 39 patients who received 12 weeks of additional standard therapy following 12 weeks of the combination therapy, a total of 33 patients in three different dosage arms showed sustained viral response a month later.

Continue reading this entire article:
http://www.reuters.com/article/2012/08/08/us-achillon-hepatitisstudy-idUSBRE87700320120808



__________________

Geno type 1b, F1 vl 640,000 enrolled in Gilead's sofosbuvir/ledipasvir -week 1 66, week 2 <25

Page 1 of 1  sorted by
 
Quick Reply

Please log in to post quick replies.

Legal Disclaimer:

THIS FORUM, IT'S OWNERS, ADMINISTRATORS, MODERATORS AND MEMBERS DO NOT AT ANY TIME GIVE MEDICAL ADVICE AND IN ALL CASES REFER ANYONE HERE TO SEEK APPROPRIATE MEDICAL ADVICE FROM THEIR DOCTOR.